Noritsu Koki Co

Noritsu Koki Co Equity

The The Equity of Noritsu Koki Co (7744.T) as of Nov 1, 2026 is 222.25 B JPY. In the previous year, The Equity was 205.38 B JPY — a change of 8.22% (higher).

Equity

222.25 BJPY

YoY

8.22%

Last updated:

In 2024, Noritsu Koki Co's equity was 222.25 B JPY, a 8.22% increase from the 205.38 B JPY equity in the previous year.

The Noritsu Koki Co Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2017
75.48 B JPY
Jan 1, 2018
74.97 B JPY
Jan 1, 2019
78.49 B JPY
Jan 1, 2020
105.41 B JPY
Jan 1, 2021
111.03 B JPY
Jan 1, 2022
192.55 B JPY
Jan 1, 2023
205.38 B JPY
Jan 1, 2024
222.25 B JPY
The Noritsu Koki Co Equity history
YEAREquityYoY
222.25 BJPY+8.22%
205.38 BJPY+6.66%
192.55 BJPY+73.42%
111.03 BJPY+5.32%
105.41 BJPY+34.31%
78.49 BJPY+4.70%
74.97 BJPY-0.68%
75.48 BJPY+31.74%
57.29 BJPY+8.98%
52.57 BJPY-6.48%
56.22 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noritsu Koki Co Stock analysis

What does Noritsu Koki Co do? Noritsu Koki Co., Ltd. generates revenue through multiple business segments including the Manufacturing segment, which produces pen nib parts and cosmetics materials. The Healthcare segment offers remote diagnostic imaging services and data analysis for healthcare providers. The Drug Discovery segment develops biotechnology products, while the Senior and Life segment manages senior publishing and mail order sales. The Agri-food segment sells fresh vegetables, and the Others segment focuses on new growth investments. The company's products are sold to various clients within each segment, such as healthcare institutions for diagnostic services, biotech firms for drug discovery solutions, and retail customers for senior publishing and fresh vegetables. The Agri-food segment's fresh vegetables are supplied to consumers through direct sales channels. Noritsu Koki's revenue streams are diversified across six distinct segments, with each segment targeting specific market needs. The Manufacturing segment serves industrial clients requiring precision components, while the Healthcare segment caters to medical facilities seeking remote diagnostic support. The Drug Discovery segment partners with biotechnology companies for innovative product development. Noritsu Koki Co is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Noritsu Koki Co's Equity

Noritsu Koki Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Noritsu Koki Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Noritsu Koki Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Noritsu Koki Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Noritsu Koki Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Noritsu Koki Co stock

The Equity of Noritsu Koki Co is 222.25 B JPY in 2024.

The Equity of Noritsu Koki Co changed from 205.38 B JPY to 222.25 B JPY, representing a 8.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Noritsu Koki Co since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Noritsu Koki Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Noritsu Koki Co

All Key Metrics — Noritsu Koki Co